Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor Conferences

News provided by

Sep 26, 2018, 16:30 ET

WASHINGTON, Sept. 26, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming 2018 investor conferences:

The Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease in New York City on Thursday, September 27, 2018. Vanda management will host investor meetings.

The Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday, October 2, 2018. A corporate presentation is scheduled for 1:05 p.m. Eastern Time.

The corporate presentation given at the Cantor Fitzgerald Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
[email protected]

SOURCE Vanda Pharmaceuticals Inc.